|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.175 USD | +0.69% |
|
-1.58% | -6.22% |
| 06-29 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) added to Russell 3000E Growth Benchmark | CI |
| 06-29 | Spero Therapeutics, Inc.(NasdaqGS:SPRO) added to Russell 3000E Index | CI |
| Market Cap | 125M 109M 101M 93.49M 177M 11.87B 180M 1.21B 470M 5.86B 470M 459M 20.25B | P/E 2024 |
-0.81x | P/E 2025 | 15.5x |
|---|---|---|---|---|---|
| Enterprise Value | 125M 109M 101M 93.49M 177M 11.87B 180M 1.21B 470M 5.86B 470M 459M 20.25B | EV / Sales 2024 |
1,170,430x | EV / Sales 2025 | - |
| Free-Float |
77.54% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Spero Therapeutics, Inc.
| 1 day | +0.69% | ||
| 1 week | -1.58% | ||
| Current month | -1.13% | ||
| 1 month | -20.26% | ||
| 3 months | -19.67% | ||
| 6 months | -14.98% | ||
| Current year | -6.22% |
| 1 week | 2.12 |  | 2.28 |
| 1 month | 1.95 | | 3.05 |
| Current year | 1.95 | | 3.08 |
| 1 year | 1.8 | | 3.22 |
| 3 years | 0.51 | | 3.22 |
| 5 years | 0.51 | | 19.87 |
| 10 years | 0.51 | | 23.64 |
| Manager | Title | Age | Since |
|---|---|---|---|
Esther Rajavelu
CEO | Chief Executive Officer | 47 | 09/01/2025 |
Timothy Keutzer
COO | Chief Operating Officer | 58 | 31/01/2023 |
Shai Biran
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milind Deshpande
CHM | Chairman | 69 | 31/12/2013 |
| Director/Board Member | 62 | 31/08/2015 | |
Frank Thomas
CHM | Chairman | 56 | 09/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Free | Director | 30,000 | 0.0518% | ||
| 06-22 | Free | Director | 30,000 | 0.0518% | ||
| 06-22 | Free | Chairman | 30,000 | 0.0518% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.69% | -1.58% | -25.68% | +46.64% | 125M | |
| -1.48% | +0.93% | +72.59% | +127.82% | 57.72B | |
| -3.80% | -6.24% | +67.04% | +86.36% | 52.65B | |
| +1.80% | +7.46% | +19.60% | +463.63% | 24.46B | |
| -1.97% | -1.31% | -16.99% | -13.72% | 23.84B | |
| -3.05% | +3.06% | +42.36% | -5.66% | 19.28B | |
| -0.24% | +5.22% | +38.91% | -25.87% | 17.8B | |
| +2.34% | +14.18% | +220.96% | +380.99% | 17.29B | |
| -6.73% | +9.90% | +36.04% | - | 15.28B | |
| -2.08% | +4.16% | +29.18% | +194.73% | 14.35B | |
| Average | -1.44% | +4.39% | +48.40% | +139.43% | 24.28B | |
| Weighted average by Cap. | -1.80% | +2.56% | +58.03% | +139.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 47.98M 41.98M 38.69M 35.86M 68.08M 4.55B 69.18M 464M 180M 2.25B 180M 176M 7.77B | 66.8M 58.46M 53.88M 49.94M 94.79M 6.34B 96.32M 646M 251M 3.13B 251M 245M 10.82B |
| Net income | -68.57M -60M -55.3M -51.25M -97.3M -6.51B -98.87M -663M -258M -3.21B -257M -252M -11.1B | 8.57M 7.5M 6.91M 6.41M 12.16M 814M 12.36M 82.9M 32.24M 402M 32.18M 31.48M 1.39B |
| Net Debt | - | - |
Employees
25
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | US$2.185 | +1.16% | 106,043 |
| 07/07/26 | US$2.160 | -1.37% | 879,844 |
| 06/07/26 | US$2.190 | -0.45% | 372,735 |
| 02/07/26 | US$2.200 | -0.90% | 629,524 |
| 01/07/26 | US$2.220 | +0.45% | 397,551 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2.160USD
Average target price
4.000USD
Spread / Average Target
+85.19%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
